Voluntary Standards
-
Charter of Conduct
This page contains the "Pharmaceutical Manufacturers Association of Japan Charter of Corporate Behavior" and other voluntary codes of conduct for member companies.
-
Pharmaceutical Association Code of Practice
The "Pharmaceutical Manufacturers Association of Japan Code of Practice," which covers interactions between all executives and employees of member companies and researchers, medical professionals, patient groups, etc. is posted.
-
Transparency Guidelines for Relationships between Corporate Activities and Medical Institutions
Transparency Guidelines for Relationships between Corporate Activities and Medical Organizations, etc. are explained.
-
Transparency Guidelines for Relationships between Corporate Activities and Patient Groups
Transparency Guidelines for Relationships between Corporate Activities and Patient Groups are available.
-
Guidelines for the Preparation of Product Information Summaries for Ethical Drugs (Abbreviated name: Preparation Guidelines)
The "Guidelines for the Preparation of Product Information Summaries for Ethical Drugs" and commentary are posted to promote the appropriateness of materials prepared by each member company.
-
Clinical Research
Basic ideas and related information on how clinical research using ethical drugs should be conducted are posted.
-
Basic Philosophy and Action Guidelines on Biodiversity
Basic Philosophy and Action Guidelines on Biodiversity" to help member companies find the best ways to harmonize their business activities with the natural environment.
-
Guidelines for Appropriate Competition in the Meetings of the Japan Pharmaceutical Manufacturers Association (JPMA)
Guidelines for meetings of the Pharmaceutical Manufacturers Association of Japan (PMAJ) are posted.
-
Guidelines for the Promotion of Pharmaceutical Industry
Guidance" and "Guidelines" established based on voluntary standards are posted.
